依达拉奉联合血栓通治疗急性脑梗死疗效观察

Clinical Curative Effect Observation of Edaravone and Unobstructed Thromb(血栓通) on Acute Cerebral Infarction

目的:探讨依达拉奉联合血栓通治疗急性脑梗死的疗效。方法:120例进展型脑梗死随机分为血栓通组(对照组)和依达拉奉联合血栓通治疗组(治疗组)。分别对两组治疗前、治疗14天后的神经功能缺损及临床疗效进行评价。结果:两组治疗后的神经功能缺损较治疗前均有显著改善(P<0.01),治疗组与对照组比较有显著性差异(P<0.01)。治疗后临床疗效评价治疗组总有效率(85.00%)与对照组(71.67%)比较有明显差异(P<0.05)。结论:依达拉奉联合血栓通治疗急性脑梗死能保护脑细胞,有效改善神经功能。

Objective ： To observe the curative effect of Edaravone and Unobstructed Thromb on acute cerebral infarction. Method： 120 cases of acute cerebral infarction were selected and divided into two groups. The cases in the treatment group were treated by Edaravone and Unobstructed Thromb, and the cases in the control group were treated by Unobstructed Thromb. The course of treatment was 14 days. Then evaluate the curative effect according to the neurologic impairment and clinical curative effect before and after treating. Result： After treatment the neu- rologic impairment in the two groups were all improved significantly （P 〈0.01 ） , and the difference between the two groups was significant （P 〈0.01 ）. About the clinical curative effect, the effective rate in the treatment group was 85.00% , and that in the control group was 71.67%. The difference between the two groups was significant （P 〈 0.01 ）. Conclusion： Edaravone and Unobstructed Thromb on acute cerebral infarction can defend brain cells from injury and improve nerves function effectively.